SN
Suparna Nag Rajak
About Suparna Nag Rajak
Data last updated:
Suparna Nag Rajak is a Director at Lorfan Pharma Private Limited (since 2024). Lorfan Pharma Private Limited reported revenue of ₹27.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lorfan Pharma Private Limited U47721WB2024PTC267243 | Director | 02 Jan 2024 | 2024 | ₹27.1 Lakh (FY 2025) | Active |
Board colleagues of Suparna Nag Rajak
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manali Ghosh | 10449835 | Lorfan Pharma Private Limited | Director |
| Rina Nag | 10449836 | Lorfan Pharma Private Limited | Director |
| Sabari Mondal | 11490227 | Lorfan Pharma Private Limited | Additional Director |
| Soma Banerjee | 10601554 | Lorfan Pharma Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suparna Nag Rajak
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suparna Nag Rajak
Suparna Nag Rajak currently holds 1 directorship: Lorfan Pharma Private Limited (Director, since 02 Jan 2024, revenue ₹27.1 Lakh (FY 2025)).
Suparna Nag Rajak was first appointed on 02 Jan 2024 as Director at Lorfan Pharma Private Limited.
The current boards of Suparna Nag Rajak's companies include Manali Ghosh (Lorfan Pharma Private Limited), Rina Nag (Lorfan Pharma Private Limited), Sabari Mondal (Lorfan Pharma Private Limited), Soma Banerjee (Lorfan Pharma Private Limited).